X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.45
Delayed Data
As of Mar 03
 +0.1199 / +5.15%
Today’s Change
1.55
Today|||52-Week Range
5.04
+23.73%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.33
Today’s open2.32
Day’s range-- - --
Volume5,808
Average volume (3 months)12,614
Market cap$27.7M
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)-83.83%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+153.36%
P/E ratio--
Price/Sales13.65
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc-0.17-3.05%
TPITianyin Pharmaceutic...+0.01+2.03%
NUINNutrastar Internatio...-0.02-2.00%
--CannaSys Inc0.000.00%
Data as of 3:04pm ET, 03/03/2015

Financials

Last reporting dateSeptember 8, 2008
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$2.4M
Annual profit (last year)-$2.5M
Net profit margin-104.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Herzliya, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account